Cargando…
The role of latency reversal in HIV cure strategies
One strategy to eliminate latently infected cells that persist in people with HIV on antiretroviral therapy is to activate virus transcription and virus production to induce virus or immune‐mediated cell death. This is called latency reversal. Despite clear activity of multiple latency reversal agen...
Autores principales: | Tanaka, Kiho, Kim, Youry, Roche, Michael, Lewin, Sharon R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514955/ https://www.ncbi.nlm.nih.gov/pubmed/36029233 http://dx.doi.org/10.1111/jmp.12613 |
Ejemplares similares
-
Limitations of dual‐fluorescent HIV reporter viruses in a model of pre‐activation latency
por: Kim, Youry, et al.
Publicado: (2019) -
HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
por: Denton, Paul W.
Publicado: (2022) -
CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies
por: Gray, L R, et al.
Publicado: (2016) -
Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
por: Delannoy, Aurélie, et al.
Publicado: (2019) -
New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
por: Bricker, Katherine M., et al.
Publicado: (2021)